Ixekizumab, sold under the brand name Taltz, is an injectable medication for the treatment of autoimmune diseases. Chemically, it is a form of a humanized monoclonal antibody. The substance acts by binding interleukin 17A and neutralizing it, reducing inflammation.
Ixekizumab, sold under the brand name Taltz, is an injectable medication for the treatment of autoimmune diseases. Chemically, it is a form of a humanized monoclonal antibody. The substance acts by binding interleukin 17A and neutralizing it, reducing inflammation.
The most common side effects include upper respiratory infections, injection site reactions and fungal (tinea) infections.
via Wikipedia infobox
via PubMed
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).